Human-Chimpanzee Differences in a FZD8 Enhancer Alter Cell-Cycle Dynamics in the Developing Neocortex  by Boyd, J. Lomax et al.
ReportHuman-Chimpanzee Differences in a FZD8
Enhancer Alter Cell-Cycle Dynamics in the
Developing NeocortexGraphical AbstractHighlightsd Discovery of a human-accelerated enhancer functioning in
the developing neocortex
d Compared to chimpanzee, human HARE5 drives earlier and
more robust brain expression
d The HARE5 locus physically contacts the core promoter of
the WNT receptor, Fzd8
d HARE5::Fzd8 mice have an accelerated neural progenitor
cell cycle and enlarged brainsBoyd et al., 2015, Current Biology 25, 772–779
March 16, 2015 ª2015 Elsevier Ltd All rights reserved
http://dx.doi.org/10.1016/j.cub.2015.01.041Authors
J. Lomax Boyd, Stephanie L. Skove, ...,
Gregory A. Wray, Debra L. Silver
Correspondence
debra.silver@duke.edu
In Brief
This study reports the discovery of a
human-accelerated enhancer of Fzd8
functioning in brain development. Boyd
et al. demonstrate species-specific
activity differences and show that the
human enhancer promotes a faster
progenitor cell cycle and increased
neocortical size. Enhancer sequence
changes may contribute to unique
features of the human brain.
Human-Chimpanzee DifferenCurrent Biology 25, 772–779, March 16, 2015 ª2015 Elsevier Ltd All rights reserved http://dx.doi.org/10.1016/j.cub.2015.01.041Report
ces
in a FZD8 Enhancer Alter Cell-Cycle
Dynamics in the Developing NeocortexJ. Lomax Boyd,1 Stephanie L. Skove,1 Jeremy P. Rouanet,1
Louis-Jan Pilaz,1 Tristan Bepler,2 Raluca Gordaˆn,2,3
Gregory A. Wray,2,4,5 and Debra L. Silver1,6,7,8,*
1Department of Molecular Genetics and Microbiology, Duke
University Medical Center, Durham, NC 27710, USA
2Center for Genomic and Computational Biology, Duke
University, Durham, NC 27708, USA
3Department of Biostatistics and Bioinformatics, Duke
University Medical Center, Durham, NC 27710, USA
4Department of Biology, Duke University, Durham,
NC 27708, USA
5Department of Evolutionary Anthropology, Duke University,
Durham, NC 27708, USA
6Department of Cell Biology, Duke University Medical Center,
Durham, NC 27710, USA
7Department of Neurobiology, Duke University Medical
Center, Durham, NC 27710, USA
8Duke Institute for Brain Sciences, Durham, NC 27710 USA
Summary
The human neocortex differs from that of other great apes in
several notable regards, including altered cell cycle, pro-
longed corticogenesis, and increased size [1–5]. Although
these evolutionary changes most likely contributed to the
origin of distinctively human cognitive faculties, their ge-
netic basis remains almost entirely unknown. Highly
conserved non-coding regions showing rapid sequence
changes along the human lineage are candidate loci for
the development and evolution of uniquely human traits.
Several studies have identified human-accelerated en-
hancers [6–14], but none have linked an expression differ-
ence to a specific organismal trait. Here we report the
discovery of a human-accelerated regulatory enhancer
(HARE5) of FZD8, a receptor of the Wnt pathway implicated
in brain development and size [15, 16]. Using transgenic
mice, we demonstrate dramatic differences in human and
chimpanzee HARE5 activity, with human HARE5 driving
early and robust expression at the onset of corticogenesis.
Similar to HARE5 activity, FZD8 is expressed in neural pro-
genitors of the developing neocortex [17–19]. Chromosome
conformation capture assays reveal that HARE5 physically
and specifically contacts the core Fzd8 promoter in the
mouse embryonic neocortex. To assess the phenotypic
consequences of HARE5 activity, we generated transgenic
mice in which Fzd8 expression is under control of ortholo-
gous enhancers (Pt-HARE5::Fzd8 and Hs-HARE5::Fzd8). In
comparison to Pt-HARE5::Fzd8, Hs-HARE5::Fzd8 mice
showed marked acceleration of neural progenitor cell cycle
and increased brain size. Changes in HARE5 function
unique to humans thus alter the cell-cycle dynamics of a
critical population of stem cells during corticogenesis and
may underlie some distinctive anatomical features of the
human brain.*Correspondence: debra.silver@duke.eduResults
Identification of Human-Accelerated Enhancer Loci in the
Developing Neocortex
The dramatic expansion of the neocortex during hominoid
evolution is proposed to underlie the emergence of our
uniquely human cognitive abilities [20–22], although strong ge-
netic correlations between these traits have remained elusive
[23]. The evolution of human cortical features, such as
enlarged brain size, has been attributed to cellular changes
including neuron number and neural progenitor cell cycle
[1–5, 15]. However, the genetic basis for these traits, which
so markedly distinguish humans from other primates, remains
poorly understood. Mutations within regulatory elements have
been proposed to play a significant role in the evolution of hu-
man-specific traits [24, 25]. Recent genomic studies support
this notion and have collectively identified highly conserved
non-coding regions that are rapidly evolving along the human
lineage [6–10]. Of note, these human-accelerated non-coding
loci are frequently located nearby genes implicated in brain
development and function [11, 26, 27]. Together, these studies
suggest that the evolution of human neocortical traits may
have occurred through modification of cis-regulatory en-
hancers involved in brain development. Yet to date, just a
handful of human-accelerated regions have been shown to
function as forebrain enhancers [11–13], and none have been
shown to impact neocortical expansion. Here we sought to
discover human-accelerated regulatory loci important for cor-
ticogenesis in order to gain insights into the genetic basis for
the evolution of uniquely human brain features.
We identified HARE5 from an in silico screen for rapidly
evolving human non-coding regions predicted to function
as developmental enhancers in the mammalian neocortex
(Figures S1A and S1B, Table S1, and the Supplemental
Experimental Procedures) [6–8, 28, 29]. Using a standard
mouse transient transgenic assay [11, 14], we found that
HARE5 reporter activity was robust in the lateral neocortex
and dorso-lateral midbrain (15/15 embryos) (Figures 1A and
S1C). HARE5 was prioritized due to this enhancer activity
and its chromosomal location adjacent to Frizzled 8 (FZD8),
a receptor for the Wnt signaling pathway that is implicated
in neocortical development (Figure 1B) [15–18, 30, 31]. The
Homo sapiens (Hs) HARE5 ortholog contains 16 changes
compared to Pan troglodytes (Pt). Based on outgroup com-
parison, ten mutations were fixed on the human branch and
six on the chimpanzee branch since the latest common
ancestor (Figure 1B). A phylogenetic analysis of the 1.2 Kb
HARE5 locus across several great-ape species revealed a
longer branch for the Hs ortholog compared to that of Pt (Fig-
ure 1C). This is consistent with the original signature of pos-
itive selection detected in the human relative to chimpanzee
lineage [7]. Analysis of predicted transcription factor binding
sites across the HARE5 locus revealed differences, particu-
larly at human-derived mutations, for key transcription fac-
tors relevant to corticogenesis (see Table S2) [32]. Together,
these results support the prediction that Hs-HARE5 acquired
unique enhancer activity since diverging from the common
chimpanzee lineage.
AB
C Figure 1. Identification ofHs-HARE5 as aHuman-
Accelerated Neocortical Enhancer
(A) Representative E14.5 Hs-HARE5::LacZ em-
bryo stained for b-galactosidase (LacZ) activity.
Scale bars, 2 mm.
(B) Schematic of Hs-HARE5 locus on human
chromosome 10 (hg19). The 1,219-bp-long
HARE5 genomic locus with enhancer activity in-
cludes the original 619-bp human-accelerated
sequence and flanking 50 and 30 sequences. Rep-
resented below is a PhastCons conservation
track for the HARE5 locus, shown with the region
of high conservation (gray). Also shown are line-
age-specific mutations for chimpanzee (six;
arrows, above line) and human (ten; arrowheads,
bottom), including one Denisovan (red) and one
currently identified human polymorphism (blue).
(C) Maximum-likelihood phylogenetic tree for the
HARE5 orthologous locus from five anthropoid
primates.
See also Figure S1 and Table S1.
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HARE5 in the Developing Neocortex
We postulated that human and chimpanzee HARE5 might
differentially regulate gene expression during corticogenesis.
To test this, we generated independent stable mouse trans-
genic lines (Pt-HARE5::LacZ and Hs-HARE5::LacZ). Cortico-
genesis initiates at embryonic day 9.5 (E9.5) and continues
to E18.5 [2]. At E9.5, both Pt-HARE5 and Hs-HARE5
enhancer activity were undetectable (Figures 2A–2C). How-
ever, within a half day of development at E10.0, Hs-HARE5
activity was rapidly and robustly upregulated in the lateral
telencephalon (Figures 2E and 2F). In contrast, Pt-HARE5
activity in the E10.0 telencephalon was markedly weaker
and was limited to more lateral regions (Figures 2D and 2F).
This spatial difference in enhancer activity was sustained at
E10.5, as evidenced by both whole-mount embryos and
coronal brain sections (Figures 2G–2I and S2A–S2D). By
E11.5, species-specific differences in HARE5-driven LacZ
activity were still evident, although they were far less dra-
matic (Figures 2J–2L). These results indicate that HARE5
orthologs drive expression in the developing lateral telen-
cephalon. However, relative to chimpanzee, the human
enhancer has considerably earlier and robust activity during
corticogenesis.
Having established spatial and temporal differences in
chimpanzee and human HARE5 enhancer activity, we next
sought a more sensitive and dynamic readout of HARE5 tran-
scriptional activity. The LacZ protein is stable for at least
48 hr, whereas destabilized fluorescent proteins with PEST
motifs are only stable for 2 hr post-translation [33]. We
generated new stable transgenic mouse lines, Pt-HARE5::
tdTomato-PEST and Hs-HARE5::EGFP-PEST, and compared
native fluorescence in embryos co-expressing the reporters
(Figures 2M and 2N). Both orthologs drove enhancer activity
in the E11.0 neocortex; however,Hs-HARE::EGFPwas consid-
erably brighter than Pt-HARE5::tdTomato, despite tdTomato
having intrinsically brighter fluorescent emission than EGFP
(Figures 2N–2T) [33]. This reporter difference was sustained
at E12.5, though the chimpanzee enhancer remained active
(Figures 2U–2AA and S2E–S2H).We quantified enhancer activ-
ity by qRT-PCR measurement of reporter transcript levels in
E12.5 neocortices. Hs-HARE5::EGFP embryos showed 10- to30-fold higher transcript levels than Pt-HARE5::tdTomato (Fig-
ure 2BB). Hence, multiple independent reporter lines (LacZ
and fluorescent) demonstrate that, compared to chimpanzee
HARE5, human HARE5 drives dramatically higher enhancer
activity in the telencephalon.
In the E10.5 telencephalon, the predominant neural progen-
itor populations are neuroepithelial cells, and by E12.5 these
are replaced by radial glia (termed neural stem cells) [2]. At
E10.5, both enhancers were active in the majority (about
75%) of Pax6-positive neuroepithelial cells and in some
TuJ1-positive neurons (Figures S3I–S3U). At E12.5, reporter
activity was highest in the ventricular zone (VZ) (Figure S2E–
S2H), where radial glial cells reside. Thus, both human and
chimpanzeeHARE5 enhancers are active in neural progenitors
of the developing neocortex.
Chromosome Conformation Capture Detects HARE5-Fzd8
Interactions
Having established HARE5 activity within the lateral telen-
cephalon, we next sought to identify the likely target gene.
The most proximal gene, Hs-FZD8, is located 307,758 bp
downstream from HARE5 and was an obvious candidate due
to its expression in the developing human and mouse
neocortex [17–19, 30, 31]. LacZ reporter activity and Fzd8
in situ hybridization showed similar expression patterns in
E10.5 and E11.5 whole-mount embryos and neocortical sec-
tions (Figure S3; http://developingmouse.brain-map.org and
http://www.emouseatlas.org) [31]. We used chromosome
conformation capture (3C) assays [34] to test for physical
association between endogenous mouse (Mm) HARE5 and
the core Fzd8 promoter within E12.5 mouse neocortices (Fig-
ure 3A). In neocortices, we observed a strong peak of interac-
tion between Mm-HARE5 and the proximal Fzd8 promoter
compared to flanking loci (Figure 3B). In contrast, no interac-
tions were evident between Mm-HARE5 and Fzd8 in age-
matched liver, which lacks detectable HARE5 activity and
Fzd8 expression. These data indicate that HARE5 physically
and specifically associates with the core Fzd8 promoter in
the developing mouse neocortex. Given the cis-regulatory ac-
tivity of HARE5 orthologs, we propose that HARE5 functions
as a distal-acting enhancer of FZD8 during early human
neocortical development.
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Figure 2. Hs-HARE5 Activity Drives Robust, Early Enhancer Activity Relative to Pt-HARE5 during Corticogenesis
(A–L) Developmental time series of Pt-HARE5::LacZ (A, D, G, and J) and Hs-HARE5::LacZ (B, E, H, and K) reporter activity from stable transgenic lines.
Representative images of LacZ stained embryos from lateral (top) and anterior (bottom) views are shown. Enhancer activity was qualitatively scored in
the telencephalon, using the indicated scoring schema shown on the right, on a scale from no reporter activity (score 0) to full telencephalic activity (score 5)
(C, F, I, and L). The number of embryos and independent transgenic lines analyzed for each stage is listed below. Embryos were scored blindly and inde-
pendently by at least three individuals.
(M) Schematic of destabilized reporter constructs drawn to scale.
(N–AA) Representative embryos from dual reporter transgenic Pt-HARE5::tdTomato; Hs-HARE5::EGFP E11.0 (N–T) and E12.5 (U–AA) embryos detected by
brightfield (N and U), and endogenous fluorescence for tdTomato (O, Q, S, V, X, and Z) and EGFP (P, R, T, W, Y, and AA) channels. Dotted lines demarcate
dorsal neocortices of whole-mount embryos (N–P and U–W).
(Q, R, X, and Y) Coronal sections from mid-cortex (plane indicated by arrowheads in N and U) in tdTomato (Q and X) and EGFP (R and Y) channels.
(S, T, Z, and AA) High-magnification images of the lateral telencephalon for tdTomato (S and Z) and EGFP (T and AA). The number of embryos and lines for
each analysis is listed beside (U). Endogenous fluorescence images were captured using identical exposure conditions.
(BB) Graph depicting log fold changes for qRT-PCR from E12.5 neocortices. Each data point is the average fold change for an individual Hs-HARE5::EGFP
embryo relative to the aggregated average for allPt-HARE5::tdTomato embryos.mRNA input levels were normalized toGapdh. n = 4 technical replicates per
embryo; n = 9 embryos from three transgenic lines from each genotype.
Scale bars represent 1 mm (A–K), 500 mm (N–P and U–W), 150 mm (Q, R, X, and Y), and 25 mm (S, T, Z, and AA). See also Figure S2 and Table S2.
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Figure 3. 3C Analysis Showing that HARE5 Physically Contacts the Fzd8
Promoter
(A) Schematic of 3C protocol showing HARE5 and Fzd8 loci (black bars),
with the indicated TaqMan probe (blue bar), test primers (black half arrows),
and HindIII restriction sites (red lines).
(B) 3C assay of E12.5 mouse neocortices (blue dots) and liver control tissue
(red dots). The dark vertical line indicates location of TaqMan probe and
constant primer anchored within theMm-HARE5 locus. The 0 position indi-
cates ATG of Fzd8 coding sequence. The graph depicts the relative fre-
quency of interactions between Mm-HARE5 and six genomic locations.
Error bars indicate the SD.
See also Figure S3.
775Human HARE5 Accelerates Neural Progenitor Cell Cycle
and Impacts Neocortical Size
We next assessed the functional consequences of chim-
panzee and human HARE5 activities during corticogenesis.
We generated new independent transgenic mouse lines in
which Hs-HARE5 or Pt-HARE5 drove expression of a MYC-
tagged mouse Fzd8 coding sequence (Pt-HARE5::Fzd8 and
Hs-HARE5::Fzd8; Figure 4A). Expression of MYC in embryonic
neocortices was confirmed by western blot analysis (Fig-
ure S4A). We postulated that Fzd8 expression driven by the
HARE5 enhancer would impact the cell-cycle state of neural
progenitors based upon the following rationale. First, both
Hs-HARE5 and Pt-HARE5 drive expression in neural progeni-
tors. Second, modulation of Fzd8 levels impacts the neural
progenitor cell cycle in the retina [18]. Third, overexpression
of stabilized b-catenin, a Wnt signaling component down-
stream of Frizzled, induces an expanded and gyrencephalic
brain and slows cell-cycle exit of neural stem cells in mice
[15]. Fourth, cell-cycle length is critical for corticogenesis
and is postulated as a likely mechanism for the evolutionary
expansion of the primate neocortex [35, 36].
We measured the cell-cycle state of progenitors at E12.5,
predicting that species-specific differences in HARE5 activity
would be evident within two days of onset of enhancer activity.At this stage, radial glial progenitors primarily undergo sym-
metric divisions to expand laterally, but a subset of these
divide asymmetrically to produce excitatory neurons [2]. Quan-
tification of G2/M phases using phospho-histone H3 (PH3)
staining revealed a significant 1.3-fold increase in the propor-
tion of total PH3-positive cells in Hs-HARE5::Fzd8 brains rela-
tive to both Pt-HARE5::Fzd8 and non-transgenic wild-type
(WT) littermates (Figures 4B–4E). We also observed a trend
toward more Pax6-positive radial glia in Hs-HARE5::Fzd8
brains, with a significant increase relative to the WT (Fig-
ure S4B). These snapshot measurements indicate that at
E12.5,Hs-HARE5-driven expression of Fzd8 alters the prolifer-
ating population. More G2/M-positive progenitors may indi-
cate a faster overall cell cycle with similar G2/M phases or,
alternatively, an identical cell cycle with longer G2/M.
To help discriminate between these possibilities, we quanti-
fied cell-cycle duration at E12.5. We used a paradigm of 2 hr
BrdU exposure and 30 min EdU exposure coupled with Ki67
staining, as previously described [37] (Figure 4F). Both WT
and Pt-HARE5::Fzd8 progenitors cycled for about 12 hr,
as previously reported for this age [37, 38]. In contrast,
Hs-HARE5-driven Fzd8 expression significantly accelerated
both the total cell cycle (to approximately 9.2 hr) and S phase,
by 25% (Figures 4G–4J and Table S3). These cell-cycle differ-
ences correspond to a 23% shorter G1/G2/M duration (Tc-Ts)
of Hs-HARE5::Fzd8 progenitors compared to Pt-HARE5::Fzd8
(p = 0.003). Thus, this functional analysis reveals that relative to
both the WT and Pt-HARE5::Fzd8, human HARE5-directed
expression of Fzd8 accelerates neural progenitor cell cycle.
Increased proliferation of neural progenitors is frequently
associatedwith changes in brain size. Therefore, wemeasured
the cortical dimensions of transgenic E18.5 brains. Compared
to Pt-HARE5::Fzd8 and WTs, the dorsal area of Hs-
HARE5::Fzd8 cortices was significantly larger by 12% (Figures
4K–4O). Across five additional measurements, Hs-HARE5::
Fzd8 cortices were consistently larger than both Pt-HARE5::
Fzd8 and WTs (Figures S4F–S4H). As a larger cortical area
could be due to increased cortical thickness or tangential
length, we quantified these dimensions in sagittal and coronal
sections (Figures 4P–4S).Hs-HARE5::Fzd8 brains were thinner
than Pt-HARE5::Fzd8 and WT brains, although differences
were only significant in comparison to the WT (Figure S4I). In
contrast, compared to both Pt-HARE5::Fzd8 and WTs, Hs-
HARE5::Fzd8 brains showed significantly longer tangential
distance along the cortical VZ (Figure 4S). As seen in other mu-
tants with longer tangential growth, Hs-HARE5::Fzd8 brains
also showed enlarged ventricles. The increased tangential
length phenotype is often associated with greater progenitor
proliferation and larger cortical size, as evidenced in mouse
embryonic brains mis-expressing b-catenin or FGF2 [15, 39].
These data indicate that tangential expansion is a likely
contributing factor for the increased cortical area.
We predicted that faster progenitor proliferation would ulti-
mately be associated with more neurons. To test this, we
quantified the densities of FoxP1-positive neurons (mid-layers
III–V), born between E13.5 and E16.5, and FoxP2 neurons
(deep-layer VI), born around E12.5 (Figures 4T–4AA), within
radial columns of E18.5 brains [40, 41]. Compared to chim-
panzee, Hs-HARE5::Fzd8 brains showed a significant 14% in-
crease in the density of FoxP1 neurons, but no difference in
FoxP2 neurons, nor any notable apoptosis. Thus, Hs-
HARE5::Fzd8 brains contain a higher density of neurons that
are produced beginning around E13.5. Together, these data
indicate that compared to Pt-HARE5, Hs-HARE5 promotes
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Figure 4. Hs-HARE5-Driven Expression of Fzd8 Accelerates the Cell Cycle of Neural Progenitors and Increases Neuron Number and Neocortical Size
(A) Schematic of Pt-HARE5::Fzd8 and Hs-HARE5::Fzd8 constructs.
(B–I) Images of coronal sections from E12.5 WT littermate (B and G), Pt-HARE::Fzd8 (C and H), and Hs-HARE5::Fzd8 (D and I) transgenic cortices. Sections
were stained for PH3 (green) and Hoechst (blue) (B–D) or BrdU (green) and EdU (red) (G–I). A graph ofWT (white),Pt-HARE::Fzd8 (gray), andHs-HARE5::Fzd8
(black) depicting percentage of all cells that are PH3-positive is shown in (E). The paradigm for analysis of cell-cycle length using double pulse of BrdU and
EdU is shown in (F). Nucleotide analogs were injected at the indicated time points, and overall cell-cycle length (Tc) and S phase length (Ts) were calculated
as shown.
(J) Graph of WT (white), Pt-HARE::Fzd8 (gray), and Hs-HARE5::Fzd8 (black) cell-cycle lengths of cycling progenitors.
(K–M) Whole-mount E18.5 brains from the indicated genotypes (n, number of brains examined). A dotted line was drawn on the WT cortex in (K) to indicate
dorsal cortical area and was then superimposed on transgenic cortices in (L) and (M).
(N) Schematic cartoon representation of E18.5 brain with indicated regions of analyses for sagittal sections (P–S) and coronal sections (T–AA).
(legend continued on next page)
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777faster progenitor cell cycle, which is ultimately associated with
increased Foxp1 excitatory neuron density, and overall larger
cortical size.
Discussion
The neocortex expanded spectacularly during human evolu-
tion, giving rise to distinctively human anatomical and cogni-
tive capabilities [1, 2, 20–22]. Yet to date, just a handful of
genetic loci have been associated with human-specific brain
traits [3, 5, 25], and none have been shown to functionally
impact corticogenesis in an evolutionarily divergent fashion.
In this study, we report the discovery of the first human-accel-
erated enhancer that functions in brain development. We
demonstrate dramatic temporal and spatial differences in
activity of human and chimpanzee enhancers of FZD8 during
early corticogenesis and show that these differences impact
neural progenitor cell cycle and brain size. Our study suggests
the intriguing hypothesis that evolutionary changes in HARE5
sequence and activity contributed to the origin of unique fea-
tures of the human brain.
The evolutionarily divergent activities of HARE5 support a
model proposed 16 years ago by Pasko Rakic: that species
differences in progenitor proliferation may contribute to dis-
tinctions in brain size between humans and non-human pri-
mates [36]. The proposed radial unit hypothesis predicts that
the number and proliferative capacity of progenitor cells drives
the evolution of brain cytoarchitecture and explains species
differences in neocortical size and structure. Indeed, both
empirical and predicted measurements of the neural progeni-
tor cell cycle reveal stark differences between humans, non-
human primates, and mice [1, 36, 42]. In non-human primates,
distinct G1 phase durations are associated with unique brain
cytoarchitecture [35]. Moreover, genetic evidence strongly
supports a causal link between neural stem cell proliferation
and human brain size [43].
How might a faster cell cycle impact human brain size? We
speculate that in the context of extended human corticogene-
sis and gestation, HARE5 increases progenitor proliferation,
which expands the progenitor pool during early corticogene-
sis. Increased progenitor expansion would ultimately produce
more neurons and a larger neocortex. This could involve
altering progenitor cell-cycle exit and/or the division state of
progenitors from neurogenic to proliferative. In E14.5 mice,
proliferating and neurogenic neural progenitors have distinct
S phase durations [44]. Experimental shortening of the G1
phase in mice promotes proliferative divisions in lieu of neuro-
genic divisions, impacting neuron production [45, 46]. Our
study implicates shorter G1 as a potential mechanism, as the
Tc-Ts fraction was shorter in human transgenic brains.
Follow-up studies of the Hs-HARE5::Fzd8 mouse will clarify(O) Graph of WT (white), Pt-HARE::Fzd8 (gray), and Hs-HARE5::Fzd8 (black) do
HARE5::Fzd8 cortical area.
(P–R) Sagittal E18.5 sections from brains of indicated genotypes. A line drawn o
transgenic cortices in (Q) and (R). Note no evidence of cortical gyrification wa
(S) Graph depicting ventricular length for indicated genotypes.
(T–V and X–Z) Coronal E18.5 sections from neocortices of indicated genotypes
was observed.
(W and AA) Graphs depicting densities of Foxp1 (W) and Foxp2 (AA) neurons
The followingwere analyzed for each genotype: for (B)–(E), n = 5 embryos each f
three transgenic lines; for (K)–(O), 16–57 embryos each from two to three tran
embryo) from two to three transgenic lines; and for (T)–(AA), five to six embryo
All analyses were done blind to genotype. Error bars indicate the SD. *p < 0.05, *
(P–R), and 100 mm (T–Z). See also Figure S4 and Table S3.the detailed relationship between altered cell cycle and brain
size and elucidate whether modifications in structural and
behavioral traits exist.
Wehave shown that a key target geneofHARE5 activity in the
neocortex is FZD8, which encodes a Wnt receptor. Given the
neurogenesis roles of b-catenin and Lef/Tcf, it is likely that
FZD8 acts via canonical Wnt signaling [16]. FZD8 expression
in the neonatal human brain is highest in cortical areas at
9weeks post-conception (http://brainspan.org) [19], when neu-
ral stem cells are rapidly expanding during early corticogenesis
[2], but is markedly lower in non-cortical areas. The FZD8
expression pattern correlates strongly with the neural stem
cell markers SOX2 and PAX6 (r > 0.90) [19, 47]. Hence, the
pattern of HARE5 activity and FZD8 expression is consistent
with a functional relationship in neural stemcell regulation in hu-
mans. Although chimpanzee expression data are not available,
developing rhesusmacaque (Macacamulatta) neocortical data
are (http://www.blueprintnhpatlas.org).Relative to tencommon
transcripts of human and macaque developing neocortices,
FZD8 was more abundant in humans. As RNA expression data
become available [48], it may become possible tomore directly
compare FZD8 levels in human and non-human primates.
In addition to its requirement for early mouse corticogene-
sis, Wnt signaling is implicated in human brain traits. In 2002,
Chenn et al. showed that expression of stabilized b-catenin
induced a larger, gyrencephalic phenotype reminiscent of
the human brain [15]. However, evidence for the involvement
of this pathway in human brain evolution has remained elusive
until now. Our identification of HARE5 highlights the transcrip-
tional regulation of Wnt signaling components as a new
avenue to explore for understanding the evolutionary origin
of human-specific anatomical and cognitive traits. With the
ability to identify regulatory elements active during develop-
ment [49], we are now poised for the discovery of additional
loci and pathways whose modification provided the underpin-
nings for the evolution of the human brain.
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